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Appraisals in Menopause
Abstract
Menopause is a prevalent concern for women ranging from the ages of 40 to 60, as it is 
often associated with significant amounts of physical and emotional distress. Previous 
research has shown an association between women’s attitudes toward menopause and the 
decision to seek hormone replacement therapy (HRT). In addition, research has shown 
that women who suffer from many physical symptoms tend to seek HRT. However, 
there is a lack of research investigating how physical symptoms during menopause may 
affect the relationship between attitudes toward menopause and the decision to seek 
HRT, anti-depressant medication, or psychotherapy. The present study examined 
whether symptom severity served as a significant mediator between menopausal attitudes 
and the decision to seek HRT or anti-depressant medication during the menopausal 
transition. Ninety-five postmenopausal women completed a General Information 
Questionnaire, the Menopause Attitude Scale, the Menopause Representations 
Questionnaire, the Women’s Health Questionnaire, and the NEO Five Factor Inventory. 
Results indicated that symptom severity significantly mediated the relationship between 
two menopausal attitudinal variables (general attitudes toward menopause and 
perceptions that menopause has had a negative impact on one’s life) and treatment- 
seeking. Additional analyses revealed that women who sought treatment experienced 
more symptoms than those who did not, past reproductive events were not predictive of 
treatment-seeking or physical and emotional distress during the menopausal transition, 
and that those who had experienced surgical menopause had a more positive general 
attitude toward menopause than those who had experienced natural menopause. Further, 
it was revealed that a dissatisfaction with one’s social life predicted both treatment- 
seeking and physical and emotional distress during the menopausal transition.
i
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Appraisals in Menopause 1
Cognitive Appraisals, Symptom Severity, and Obtained Treatment During the 
Perimenopause: A Retrospective Study 
Menopause is a time in a woman’s life that brings about great change and often a 
great deal of frustration and confusion. It is traditionally defined as a woman’s final 
menstruation, which occurs during the climacteric (Smith & Judd, 1994). The 
climacteric is a general term used to describe the phase of the aging process in which a 
woman passes from a reproductive to a non-reproductive period, consisting of three 
stages: perimenopause, menopause, and postmenopause (Smith & Judd, 1994). The 
perimenopausal period occurs when the menstrual cycle becomes irregular and when 
other symptoms begin to develop, and is often called the menopausal transition. 
Menopause refers to a specific event, a woman’s final menstruation. Further, 
postmenopause refers to the phase of life that follows the final menstrual period (Smith & 
Judd, 1994). The standard confirmation of menopause occurs after 12 consecutive 
months without menstruation in the absence of any pathological or physical cause that 
would terminate menstruation (North American Menopause Society, 2003). Currently, 
women in the United States typically experience menopause between the ages of 40 and 
58, with the mean age of 51 (North American Menopause Society, 2003). However, 
women may experience menopause anywhere between the ages of 30 and 60.
History o f Menopausal Research
Historically, menopause has been a topic of curiosity, although it was rarely 
discussed in the social realm. It has only been in the past few decades that some 
researchers have systematically studied the menopausal process and its symptoms. The 
term “menopause” was derived from the Greek words “men” (meaning “month”) and 
“pauses” (meaning “cessation”). The term “climacteric” originated from the Greek term
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for “ladder” or “steps of a ladder” (Utian, 1997). In the 4th century B.C., Aristotle and 
many other philosophers in classical Greece and Rome cited the age of menopause to 
occur between 40 and 50 years of age. By the 7th century A.D., writers were in accord 
that the minimum age for menopause was 35, the average age was 50 and the maximum 
age was 60 (Amundson & Diers, 1973). In the 18th century, treatment for menopause 
was aimed at alleviating psychological symptoms or curing the “diseases” that were 
thought to be tied to the menopausal transition. During this time, treatments varied from 
blood-letting to purgatives to the consumption of raw eggs (Utian, 1997).
The treatment of menopausal symptoms has become gradually more scientific, 
and in 1896, three reports were published on the topic of hormone replacement therapy 
(HRT) (Utian, 1997). Since that time, HRT has grown in popularity due to increased 
availability and demand, but has become increasingly controversial. HRT has been 
associated with complications including endometrial cancer, breast cancer, hypertension, 
and gallbladder disease (Smith & Judd, 1994). Currently, there is a wealth of information 
in books, on the internet, and in the media for women experiencing menopausal 
symptoms.
Theories o f Menopause
Reproductive cessation has been documented in both human and non-human 
female primates, lions, and a number of other mammals (Packer, Tartar, & Collins,
1998). Thus, human females and some other mammalian females live for an extended 
period of time after their ability to reproduce ceases. This is not true for all species, nor is 
it true for human males who can retain their fertility until they are as old as 94.20 years 
(Silber, 1991). The menopausal transition is particularly noteworthy for humans because 
it serves as a significant outlier in normal reproductive progression. Given that the life
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expectancy for females is 82.4 years (Statistics Canada, 2003), women are living an 
average of 32.4 years after their ability to reproduce ceases. Theories about menopause 
can help explain why this occurs and help determine if menopause is a simple anomaly or 
if it serves a specific evolutionary function. Currently, there are four evolutionary 
hypotheses for why the cessation of reproduction occurs in mammals.
One hypothesis posits that women experience menopause because they are living 
longer due to medical advances and associated decreases in mortality rates (Sherman, 
1998). This can also be seen with mammals being kept in artificial zoo environments that 
live much longer than they would in their natural environment. Ultimately, menopause 
occurs because the lifespan has increased in mammals with a finite number of eggs 
(Austad, 1994). During the second trimester, the ovaries in the human fetus have 7 
million ovarian follicles that have the potential to become eggs. When the infant is bom, 
this number is reduced to 40,000, and about 400 develop into eggs and are shed during 
the female’s lifetime (Baker & Beilis, 1995). These eggs deplete throughout the lifespan, 
and eventually menopause occurs when few eggs are left. In other words, the number of 
years that women are living is increasing, but the number of eggs that a female produces 
cannot be changed - it is fixed at birth.
A second hypothesis states that menopause occurs because age causes a 
deterioration of the once well-regulated physiological process of reproduction (Sherman, 
1998). This process is similar to the degeneration of eyesight or hearing with age, or 
urinary incontinence with the deterioration of nerve and muscular bladder control. This 
occurs because a species has outlived the span of time that they were “designed” (i.e., 
evolved) to survive (Austad, 1994). This is also simply called the “senescence”
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explanation, and support for this theory has been found in females of two mammalian 
species to date (Packer, Tartar, & Collins, 1998).
A third hypothesis is an adaptive evolutionary hypothesis positing that menopause 
occurs to protect the gene pool because birth defects increase with maternal age 
(Sherman, 1998). Therefore, mammals have evolved to stop reproducing after a certain 
age in order to keep genetic defects out of the population. Joseph and colleagues (2005) 
found that older maternal age was associated with higher rates of preterm birth, perinatal 
mortality, and fetal-growth restriction (see also Cleary-Goldman et al., 2005). This trend 
can also be found in other mammals. For example, baboon pregnancies are more likely 
to end in miscarriage after the female baboon reaches the age of 21 years (Packer, Tartar, 
& Collins, 1998). In addition to birth complications, genetic defects in offspring become 
more prevalent as maternal age increases. For example, the frequency of infants bom 
with Down’s syndrome compared to normal births increases from 1/1400 for women 
between the ages of 20 to 24 to 1/350 for women who are 35 years of age (Hook, Cross, 
& Schreinemachers, 1983).
Finally, the “grandmother” hypothesis proposes that mammals stop reproducing 
in order to best care for their offspring so the offspring will grow to be healthy and 
ultimately reproduce themselves (Alvarez, 2000). After an offspring is born, a mother 
must devote an increased amount of energy in order to care for a newborn, and may 
neglect other dependents. Menopause allows a mammal to stop reproducing and focus 
their attention on their already-present offspring and the children of their offspring 
(Alvarez, 2000). In evolutionary terms, this is essentially a form of inclusive fitness 
(Hamilton, 1964) or kin selection (Maynard Smith, 1964).
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Appraisals in Menopause 5
Despite the ability of various theories to explain disparate areas concerning the 
onset of menopause, a singular unifying theory has yet to be obtained.
Stages o f Menopause
Women may experience either physiological or surgical menopause.
Physiological menopause occurs as a natural process as oocytes (eggs) in the ovary begin 
to disappear and the few remaining oocytes do not respond to gonadtropins such as 
luteinizing hormone (LH) and follicle-stimulating hormone (FSH). Surgical menopause, 
however, occurs when the ovaries are removed or from exposure to radiation therapy, and 
may occur at any age (Smith & Judd, 1994).
After menarche and prior to the menopausal transition, women experience 
hormonal fluctuations according to a 28-day cyclic pattern. In a regular menstrual cycle, 
ovarian estrogen determines the cyclic pattern of both FSH and LH. Around the 
midpoint of the cycle, high levels of estrogen allow the walls of the uterus to thicken and 
signal to the pituitary gland to release both FSH and LH. Typically, estrogen levels peak 
at day 12, and FSH and LH levels tend to peak at day 13 (Coulam, 1986). After these 
hormones are released, ovulation occurs.
During perimenopause, hormone levels change significantly. The level of 
estrogens, which are involved in thickening the endometrium and other aspects of 
menstrual regulation, drop off significantly during this time. In addition, the levels of 
androgen also plummet (Smith & Judd, 1994). As hormonal levels change, cyclic 
intervals begin to shorten and ovulation becomes unpredictable (Prior, 1998).
Following menopause, the level of estrogen within the female remains low. 
However, testosterone levels (an androgen) tend to increase in each decade that follows 
the menopausal transition (Cutler & Garcia, 1992). In addition, the gonadtropins, LH and
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FSH, rise substantially to stimulate the ovaries to increase estrogen production. Due to 
the cessation of ovarian follicular activity, the oocytes become unresponsive to the 
gonadtropins and the FSH and LH levels in the body remain high (Smith & Judd, 1994). 
Signs of Menopause
Typically, the first sign of menopause that women experience is irregular menses, 
which occurs when both the amount and duration of menstrual flow decrease, eventually 
tapering to spotting and cessation (Smith & Judd, 1994). However, the cessation of 
menstruation varies between women. Some women may experience a sudden 
disappearance of menstruation and a quick course of menopause, while other women may 
experience a gradual cessation. In addition, some women may suffer substantially from 
the accompanying menopausal changes, while some are not bothered by them 
(Dennerstein, 1996).
The most common menopausal symptom is the hot flush, which is an 
uncomfortable sensation consisting of sudden flushing of the skin (Kronenberg, 1990). 
Women who experience hot flashes typically experience a feeling of heat or burning in 
the neck, face and chest area, which is followed by an outbreak of sweating and a 
possible feeling of weakness (Smith & Judd, 1994). However, the characteristics of a hot 
flash vary both between and within individuals (Kronenberg, 1990). Approximately 75 
percent of women who experience menopause suffer from hot flashes and 82 percent of 
these women continue to suffer for more than a year (Smith & Judd, 1994). However, 
hot flashes may continue for up to five years for many women (Kronenberg, 1990). Hot 
flashes may last for an average of four minutes and can occur from one to two times per 
hour to one to two times per week (Smith & Judd, 1994).
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Another common menopausal symptom is insomnia due to night sweats, the 
night-time equivalent of hot flashes. Sleep may be frequently disrupted by 
uncomfortable sweating, which may lead to various cognitive and affective problems 
including irritability and memory loss (Smith & Judd, 1994). Night sweats and hot 
flashes are not the sole contributors to poor sleep patterns during the menopause, 
however, as higher anxiety levels, higher depression levels, and lower levels of estradiol 
have also been associated with poor menopausal sleep patterns (Hollander et al., 2001).
Women experiencing menopause typically encounter many physical changes of 
the reproductive area. For example, vaginal tissue tends to become thin and dry, with 
less elasticity, leading to vaginal atrophy (North American Menopause Society, 2003). In 
addition, vaginal lubrication decreases, leading to painful intercourse and post-coital 
bleeding (Bachmann, 1990). Further, atrophy of the uterus, and regression of breast size 
may occur (Smith & Judd, 1994). These reproductive changes may lead to a decreased 
sense of well-being and may decrease sexual desire and pleasure. Moreover, some 
individuals may experience heightened anxiety during sexual intercourse, stemming from 
the physical changes of their reproductive organs, which may also lead to decreased 
pleasure (Bachmann, 1990).
Up to 30 percent of women experience urinary incontinence during mid-life, 
which may be caused by a decrease in estrogen leading to a thinning of the lining of the 
urethra (North American Menopause Society, 2003). Although not all women suffer 
from urinary incontinence, women experiencing menopause may feel the need to urinate 
more often, may experience painful urination, or may experience the need to get out of 
bed several times per night to urinate (North American Menopause Society, 2003).
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Other common physical symptoms include thinning and loss of elasticity of the 
skin, changes in patterns of body hair, and a redistribution of body weight (Smith & Judd, 
1994). Typically, skin loses collagen and elasticity with age, which results in wrinkling. 
These changes are particularly evident in the areas that are exposed to light, such as the 
face, neck, and hands (Smith & Judd, 1994). Women experiencing menopause may also 
notice changes in patterns of their body hair. Typically, there is a loss of pubic hair, as 
well as a loss of hair on the upper lip, chin and cheeks. However, there may be an 
increase in coarse, terminal hair on the upper lip due to the imbalance of androgen to 
estrogen that occurs during the menopausal transition (Smith & Judd, 1994). In terms of 
body weight, women experiencing menopause typically notice an increased distribution 
of fat over the hips and abdomen (Smith & Judd, 1994).
In addition to physical changes, menopause can contribute to psychological 
changes within the individual. Common psychological symptoms include a variety of 
mood states, including anxiety, irritability, depression, frustration, and fatigue (Rasgon et 
al., 2005). Moreover, these psychological symptoms may contribute to increased stress, 
or an increased vulnerability to stressful situations that may arise (North American 
Menopause Society, 2003). Harlow and colleagues (1999) conducted a cross-sectional 
study of 4161 premenopausal women and found that 43.2 percent of all women sampled 
reported a continuous two week period of depressive symptoms. Moreover, 22 percent of 
these women scored above 16 on the Center for Epidemiologic Studies Depression Scale 
(CES-D), and 8.6 percent reported scores of 25 or greater. It should be noted that scores 
on the CES-D do not necessarily indicate a formal diagnosis of depression, but scores of 
16 and above do suggest a diagnosis of a major depressive episode or significant 
depressive symptomatology (Harlow et al., 1999). Further, a National Comorbidity
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Survey found that 5 percent of women between the ages of 45 and 54 are currently 
suffering from an episode of major depression (Blazer et al., 1994).
Measurement o f Menopausal Complaints
Given the scope and potential impact of the varied symptoms of the menopausal 
transition, it is imperative that the symptoms of menopause can be quantified and 
measured with some degree of objectivity. Indeed, a number of researchers have 
developed measures to assess the severity of menopausal symptoms.
One of the first scales developed to measure menopausal symptoms was the 
Greene Climacteric Scale in 1976, which was later revised in 1998 (Greene, 1998). 
Originally, the Greene Climacteric Scale was designed to rationally measure climacteric 
symptoms and the resulting scale consisted of three domains: psychological, somatic, and 
vasomotor. These factors correlate very little with each other and are assumed to be 
measuring separate domains. In 1998, Greene revised the scale by replacing and 
rewording items as well as breaking down the psychological domain into anxiety and 
depressed mood subscales. This scale demonstrates adequate content validity, as only 
symptoms with significant factor loadings were included, and construct validity has since 
been demonstrated in relation to life stress, HRT, and psychological treatment (Zollner, 
2005). Further, each of the subscales on the Greene Climacteric Scale demonstrates good 
reliability (Zollner, 2005).
The second major scale to tap the severity of menopausal symptoms is the 
Women’s Health Questionnaire (WHQ), which was published in 1992 (Hunter, 2003). 
This scale is composed of nine subscales including: depressed mood, somatic symptoms, 
vasomotor symptoms, anxiety/fears, sexual behaviour, sleep problems, menstrual 
symptoms, memory/concentration, and attractiveness. Concurrent validity for the
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Women’s Health Questionnaire was assessed through a comparison with the General 
Health Questionnaire (GHQ; Goldberg, 1972). The depression scale in the WHQ 
correlated .86 with the GHQ. For test-retest reliability, the correlations ranged from .78 
to .96 across a two-week interval.
A third major scale, the Qualifemme, was developed to measure the effect that 
menopausal hormone deficiency has on a woman’s quality of life (Le Floch et al., 1994). 
This scale has five domains: psychological, vasomotor, uro-genital, a general domain, 
and a domain covering pain and problems with the hair and skin. Test-retest reliability for 
the measure ranged from .84 to .98, with a Cronbach’s alpha of .73 (Le Floch et al.,
1994).
The Menopause-Specific Quality of Life (MENQOL) was developed in 1996 to 
assess menopausal symptoms, and consists of four domains: vasomotor, psychosocial, 
physical and sexual (Hilditch et al., 1996). The test-retest reliability coefficients ranged 
from .81 for the psychosocial domain to .85 for the vasomotor domain. The test-retest 
reliability for the overall QOL score was .55. Internal consistency of the measure ranged 
from .81 to .85. For construct validity, the authors determined the discriminate validity 
between each domain and a separate validating instrument and found that the validity 
ranged from .38 (between the sexual domain and its respective validating instrument) and 
.69 (between the physical domain and its validating instrument), indicating satisfactory 
construct validity.
The Menopausal Rating Scale (MRS) was also originally developed in 1996 and 
then later validated in 2000 (Schneider et al., 2000). The MRS is an 11 item scale 
covering three domains: psychological symptoms, somatovegetative symptoms, and uro­
genital symptoms. The MRS has demonstrated good construct validity with the
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Kupperman Index (Kupperman et al., 1953) and the Short-Form-36 (SF-36; Ware & 
Sherboume, 1992).
The Menopausal Symptom List (MSL) was developed in 1997 to measure the 
frequency and severity of menopausal symptoms (Perz, 1997). This scale is composed of 
three domains: psychological, vaso-somatic, and general somatic. Perz conducted test- 
retest reliability analyses for the frequency of symptom occurrence as well as the severity 
of the symptoms. For the frequency of occurrence, the test-retest reliability for the 
domains ranged from .72 (for vaso-somatic) to .92 (for general somatic). For the severity 
of symptoms, the test-retest reliability for the domains ranged from .73 (for 
psychological) to .87 (for general somatic). The MSL was correlated with the Greene 
Climacteric Scale (Greene, 1998) in order to determine convergent validity. As 
expected, the MSL and the CSRS were strongly and significantly correlated.
The Menopausal Quality of Life Scale (MQOL) was developed in 2000 to 
determine whether the quality of life for menopausal women changes with menopausal 
status in addition to other medical and lifestyle variables (Jacobs et al., 2000). This 
measure consists of both positive and negative items in 7 domains: energy, sleep, 
appetite, cognition, feelings, interactions, and symptoms impact. The internal 
consistency of the measure is excellent with a Cronbach’s alpha of .92 for the total 
MQOL and a range from .69 to .91 for each of the domains.
Lastly, The Utian Quality of Life Scale (UQOL) was redeveloped in 2002 to 
assess physical symptoms as well as a sense of well-being that is distinct from 
menopausal symptoms (Utian et al., 2002). This instrument has 4 domains: occupational, 
health, emotional, and sexual. The internal consistency of the measure as a whole is .83, 
and the test-retest reliability ranges from .75 for the emotional domain to .88 for the
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sexual domain. For construct validity, the UQOL was compared with the Short Form-36 
(SF-36; Ware & Sherboume, 1992), and was found to be correlated with the measure.
It is clear that a vast number of menopausal measures have been developed, but 
each scale differentially emphasizes domains and employs varying response formats. It 
would seem that there is ambiguity regarding the best measured aspects of menopause 
and the manner in which they should be measured.
Predictors o f Depression and Mood Disturbance in Menopause
For women, associations between depression and reproductive events throughout 
the lifespan have been extensively documented. As mentioned in the Diagnostic and 
Statistical Manual o f Mental Disorders (DSM-IV-TR), boys and girls are equally affected 
by depression prior to puberty, but depression becomes twice as common in girls after 
menarche (American Psychiatric Association, 2000). This elevated prevalence for 
depression in women continues into adulthood, and a significant proportion of women 
report a worsening of depressive symptoms during the luteal phase of their menstrual 
cycle (American Psychiatric Association, 2000; see also Brace & McCauley, 1997 for a 
review). In addition, an increased risk of depression has been observed during the 
postpartum period, as there is a rapid decline of estrogen and progesterone in the 10-day 
period following delivery (see Brace & McCauley, 1997 for a review). Ultimately, there 
is a high association between reproductive life events and an increased risk for 
depression. Following this trend, research has demonstrated an increased risk for 
depression in women going through the menopausal transition (see Avis, 2003; 
Dennerstein et al., 1999; de Novaes Soares et al., 2001; Stewart & Boydell, 1993).
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Appraisals in Menopause 13
Since depression is so prevalent during the menopausal transition, an extensive 
amount of research has been conducted to investigate the significant predictors of 
depressive symptoms during this period.
Dennerstein and colleagues (1999) conducted a prospective study investigating 
the variables that contribute to negative mood during the menopausal transition. They 
found that negative mood was predicted by baseline reports of premenstrual complaints, 
negative attitudes toward aging and menopause, and having only one child. They also 
found that the number of vasomotor and somatic menopausal symptoms, poor self-rated 
health, negative feelings towards a partner, current smoking, exercising less than once a 
week, three or more daily hassles, and moderate or high interpersonal stress also 
contributed to negative mood during the menopausal transition.
Harlow and colleagues (1999) studied the predictors of depressive symptoms in 
premenopausal women in a cross-sectional study. They found that menstrual cycle 
irregularities were unassociated with current or past depression, although premenstrual 
syndrome (PMS) symptoms such as insomnia, headaches, lack of energy, tension, and 
irritability were associated with depressive symptoms. Further, women who were 
widowed, divorced, or separated were twice as likely as married women to have 
symptoms of depression, and women with one or two children had a 30 percent lower 
risk of suffering from a mood disorder. Although the women in this study were 
premenopausal, the findings can provide valuable information as to what can trigger 
depression during the menopausal transition.
In addition to the factors mentioned above, cognitive appraisals and attitudes 
about the menopause have also been found to predict depression in the perimenopausal 
period. Hunter and O’Dea (2001) found in a retrospective study that perceptions of
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Appraisals in Menopause 14
control over the menopausal transition were negatively associated with depressed mood, 
and perceptions of negative menopausal consequences were associated with medical 
help-seeking within the past month. Moreover, Choi and colleagues (2004) found that 
perceived health status was an important predictor in menopausal depression, as was a 
negative attitude toward menopause and aging.
Predictors o f Hormone Replacement Therapy Use
Surprisingly, little research has been conducted on the variables that influence the 
use of hormone replacement therapy in menopause. Currently, research pertaining to the 
prediction of HRT use focuses on physical symptoms, attitudes toward HRT, and the 
menopausal transition.
One commonly used model in the literature investigates the severity of 
menopausal symptoms and whether or not HRT was sought. Genazzani and colleagues 
(2002) compared characteristics of women who participated in HRT to those who had not 
received treatment. They found that women who participated in HRT were more likely 
to experience menopausal symptoms for less than three years, and suggest that women 
tend to seek treatment for bothersome menopausal symptoms, which tend to be more 
frequent during the early years of menopause (Genazzani, 2002; see also Fauconnier et 
al., 2000). Moreover, research has demonstrated that women who start HRT tend to 
report more frequent hot flashes, night sweats, mood swings, irritability, and sleep 
problems prior to their HRT initiation (Bosworth et al., 2005). Also, research has shown 
that women who initiate HRT do so to relieve some of these somatic and psychological 
symptoms, increase well-being, and prevent disease (Collins & Landgren, 1997). 
Similarly, Breheny and Stephens (2001) found that postmenopausal women who had 
never used HRT reported fewer visits to the doctor and better health than women who
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had used HRT in the past or those that were currently using HRT. A strong weakness of 
this model is its omission of the attitudinal component for predicting HRT. Attitudes are 
extremely important in the decision to seek HRT, and this particular model does not 
investigate how attitudes may be influencing one’s decision to seek help.
A second model looks at how symptom severity and attitudes toward the 
menopausal transition are related. Woods and colleagues (1998) found that women who 
experienced more menopausal symptoms, and who rated themselves in poor health were 
less likely to have positive attitudes (e.g., feeling as though menopause was an 
unwelcome reminder of aging) toward the menopausal transition. Moreover, they found 
that women who had the most severe symptoms thought of menopause as an endocrine 
deficiency disease and were more likely to believe that menopause symptoms should be 
treated with hormones (Woods et al., 1998). In addition, these researchers argue that 
their findings suggest that women’s experiences during the menopause have a significant 
impact on their attitudes toward the menopausal transition, and how menopausal attitudes 
are formed (Woods et al., 1998). Other researchers have found that positive attitudes 
toward menopause were associated with fewer menopausal symptoms, or vice versa 
(Cheng et al., 2005; Papini et al., 2002; Rotem et al., 2005).
However, a third model does include HRT outcome as well as symptom severity 
and attitudinal predictors. Breheny and Stephens (2001) found that attitudes toward HRT 
and menopause were important predictors of HRT use, and they suggest that these 
attitudes may outweigh the importance of health variables. They found that a positive 
attitude toward HRT (e.g., “HRT improves the quality of life for women following 
menopause”) and a negative attitude toward menopause (e.g., “a woman feels like less of 
a woman after menopause”) significantly predicted HRT use, over and above age and
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health variables (Breheny & Stephens, 2001). However, this study investigated women 
who had completed the menopausal transition, as well as those who had not yet 
completed the menopausal transition. It is possible that women who had not yet 
completed their menopausal transition had not experienced the worst of their symptoms, 
which would have confounded the results. Without properly measuring symptom 
severity, it is hard to conclude that attitude toward the menopause is a better predictor of 
HRT than symptom severity, as the physical symptoms that one experiences could 
mediate the relationship between attitudes and the decision to seek HRT.
One study conducted by Ekstrom and colleagues (2003) did examine the 
relationship between the use of HRT and attitudes, as well as measuring physical 
symptoms. However, this study measured attitudes toward HRT itself, rather than 
attitudes toward the menopausal transition. These researchers found that participants 
who decided to use HRT had a greater number of psychological and physical symptoms, 
and were less satisfied with their overall quality of life. The researchers used a logistic 
regression analysis to determine the factors that accounted for the association between 
attitude toward HRT and the decision to use HRT. Ultimately, they found that health 
related factors explained the largest proportion of the association. Although this study 
did look at attitudes, as well as symptoms and the use of HRT, they did not directly test 
the potential mediating effects of menopausal symptoms on the relationship between 
attitudes and HRT use. Moreover, this study used attitudes toward HRT rather than 
attitudes toward the menopausal transition.
Predictors o f Psychotherapy Use During Menopause
Given the many physical and psychological changes that women experience and 
the high incidence of mood disorders during the menopausal transition, one might expect
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that there would be existing literature on predictors of psychotherapy or counselling use 
during the menopausal transition. However, a literature search was conducted using 
Medline and Psychlit with keywords “perimenopause” or “menopause” and 
“psychotherapy” or “counseling”, and the results yielded very few relevant articles. The 
available research does suggest that psychotherapy can be a beneficial treatment option 
for women suffering from both physical symptoms and psychological distress. One study 
compared the efficacy of Cognitive Behavioural Therapy (CBT) with a supportive group 
program, and found them both to be effective treatments for women going through the 
menopausal transition, although CBT was found to be more beneficial (Ayen & 
Hautzinger, 2004). Other studies have found that psychotherapy is especially helpful for 
treating stress during the menopausal transition (Busari, Osiki, & Uwakwe, 2004), the 
frequency of hot flashes and the anxiety associated with them (Hunter & Liao, 1996), 
general psychosocial difficulties (Greene & Hart, 1987), and helping to diminish negative 
beliefs during the menopausal transition (Rotem et al., 2005). Additionally, it appears 
that there are a number of self-help groups on the internet for women searching for 
support. These support groups include www.power-surge.com,
http://menopause.meetup.com/. http://www.menopauseadvice.com/. among many others. 
Despite the numerous online support groups and the few relevant research studies, the 
predictors of psychotherapy use during the menopausal transition have not been 
systematically studied.
The Present Study
The purpose of this study was to determine the relative roles of both attitudes 
towards the menopause and symptom severity in predicting HRT use, anti-depressant 
use, and psychotherapy during the menopausal transition. As discussed above, Breheny
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Appraisals in Menopause 18
and Stephens (2001) found that attitudinal predictors of HRT use may outweigh the 
importance of health variables. However, Woods and colleagues (1998) have found that 
women who experience more menopausal symptoms tend to have less positive attitudes 
toward the menopausal transition and suggest that women’s experiences during the 
menopause have an effect on how menopausal attitudes are formed. Although Ekstrom 
and colleagues (2003) have investigated the relationship between menopausal symptoms, 
attitudes toward HRT, and the decision to seek HRT, there was no research (prior to this 
study) examining the potential mediating effect of physical symptoms on the relationship 
between attitudes toward menopause and the decision to seek HRT, anti-depressant use, 
or psychotherapy. This study builds on prior research by investigating how symptom 
severity affects the relationship between attitudes toward menopause and the decision to 
seek HRT,,anti-depressants, or psychotherapy. We hypothesized that symptom severity 
would serve as a significant mediator in the relationship between attitudes toward 
menopause and HRT and anti-depressant use. Specifically, we predicted that the 
relationship between attitudes and treatment-seeking would be significant, and this 
significant relationship would disappear after symptom severity was entered into the 
equation.
In addition to testing the main hypothesis, we conducted a number of 
supplementary or exploratory analyses to examine the role of other potential variables in 
treatment-seeking or menopausal distress. Specifically, we predicted that women who 
sought treatment would have more symptoms than women who did not seek treatment, 
that past reproductive variables would predict treatment-seeking during the menopause, 
and that our general rating of menopausal distress would predict treatment-seeking.
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Method
Participants
One hundred and twenty participants were recruited to participate in this study. 
Participants were recruited through newspaper advertisements, flyers, and community 
bulletins in the Thunder Bay area. In addition, participants from other communities 
outside the Thunder Bay area learned of and participated in this study through word-of- 
mouth, or through the Lakehead University e-mail communications bulletin. The 
advertisements sought women who had completed the menopausal transition (i.e., had not 
had a menstrual period in at least 12 months).
Participants were excluded from the analyses if the subject had undergone a 
hysterectomy (n = 22), or if they had undergone a partial hysterectomy (n = 2). 
Additionally, one participant was excluded who did not indicate whether she had 
undergone a hysterectomy. Demographic variables for these groups can be found in 
Table 1.
In total, 95 participants were included in the analyses. The women ranged in age 
from 49 to 88 years (M = 59.8, SD = 8.2). The mean for age at which menopause began 
was 48.5 years (SD = 3.7), and mean length of the menopausal transition was 54.2 
months (SD = 43.7). The majority of the women were from the Thunder Bay area 
(53.7%) or other Ontario (26.3%) regions. Approximately 70 percent of participants 
were either married or living in common-law relationships, 14 percent were divorced or 
separated, 12 percent were widowed, and 4 percent were single. The majority of 
participants self-identified as Caucasian (92.6%), followed by European (5.3%), and 
Asian (1.1%). Approximately 55 percent of participants were currently employed, 40
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Table 1









Means and standard deviations
Age (Years) M  = 59.8 
(SD = 8.2)
M  = 61.4 
(SD = 10.6)
M = 57.0 
(SD = 5.2)
Age at Menopause M  = 48.5 
(SD = 3.7)
M = 41.6 
(SD =7.0)
M = 49.0 
(SD= 1.4)
Length of Menopausal Transition 
(in months)








Other regions of Ontario 
Eastern Canada 
Nunavut
51 (53.7 %) 
25 (26.3 %) 
1 (1.1%)
Raw frequencies (percent)









67 (70.5 %) 
13 (13.7 %) 
11 (11.6%) 
4 (4.2 %)
14 (63.6 %) 
5 (22.7 %) 
3 (13.6 %)







88 (92.6 %) 
5 (5.3 %)
1 (1.1 %)
21 (95.5 %) 
1 (4.5 %)






52 (54.7 %) 
38 (40.0 %) 
5 (5.3 %)
9 (40.9 %) 
9 (40.9 %) 
4(18.2 %)
2 (66.7 %) 
1 (33.3 %)
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Some High School 5 (5.3 %) 3(13.6% ) 1 (33.3%)
High school diploma 13(13.7%) 3 (13.6 %) -
Some college 5 (5.3 %) 1 (4.5 %) -
College diploma 17(17.9%) 7(31.8%) 2 (66.7 % )
Some university 11 (11.6 %) 2(9.1 %) -
Undergraduate Degree 27 (28.4 %) 4(18.2% ) -
Master’s Degree 15 (15.8 %) 2(9.1 %) -
Doctoral Degree 1 (1.1 %) - -
Type of Questionnaire:
Paper 59 (62.1 %) 16 (72.7 %) 3 (100%)
Online
U t . ,
36 (37.9 %) 6 (27.3 %) -
'Note: This table contains missing data due to unanswered items
percent were retired and approximately 5 percent were unemployed. The majority of 
participants had obtained their undergraduate degree as the highest level of achieved 
education (28.4%), followed by those achieving a college diploma (17.9%), and those 
achieving a Master’s Degree (15.8%). Approximately 62 percent of participants filled 
out the paper-and-pencil version of the questionnaire, while approximately 38 percent 
filled the questionnaire out online.
Measures
General Information Questionnaire. In order to obtain demographic information 
and information about each participant’s menstrual history, a General Information 
Questionnaire was created, and can be found in Appendix A. This questionnaire included 
questions tapping areas that have been found to be associated with depressive symptoms 
during the menopause such as perceived stress, number of children, level of exercise and 
work satisfaction, among others (see Choi et al., 2004; Dennerstein et al., 1999;
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Dennerstein et al., 2002; Harlow et al., 1999). Also included were variables found to 
predict the decision to seek HRT, such as educational attainment and socioeconomic 
status (see Bosworth et al., 2005; Ekstrom et al., 2003; Fauconnier et al., 2000). In 
addition, this questionnaire included questions regarding the participants’ sexual and 
reproductive history.
Attitudes. To measure participants’ attitudes toward the menopausal transition in 
general, the Menopause Attitude Scale (MAS; Bowles, 1986) was utilized, which can be 
found in Appendix B. This scale consists of 20 items, or 20 pairs of adjectives describing 
feelings toward the menopausal transition. Each item consists of a negative adjective 
with a response score of 1 and a positive adjective with a response score of 7. The total 
score of this measure was calculated by adding the responses. The Cronbach’s alpha for 
this measure is .96, and it has a test-retest reliability of .87. The MAS has demonstrated 
convergent validity with the Attitudes Toward Menopause Scale (Neugarten et al., 1963) 
(r = .63), and discriminant validity with the Attitudes Toward Old People Scale (Ivester 
& King, 1977) (r= .42).
In addition, we used the Menopause Representations Questionnaire (MRQ;
Hunter & O’Dea, 2001) to measure the participants’ specific attitudes toward their own 
menopause, which can be found in Appendix C. For the purposes of our study, the name 
was changed to the Menopause Experiences Questionnaire. This questionnaire differs 
from the MAS (mentioned above) because it measures attitudes toward a woman’s 
unique menopausal experiences, while the MAS measures attitudes toward the 
menopause in general. This measure demonstrates good concurrent validity as depressed 
mood on the WHQ (Hunter, 1992) is associated with negative perceptions about the 
impact of menopause (r = -.33) and beliefs that it will have a long duration (r = .33)
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(Hunter & O’Dea, 2001). The test-retest reliability for this measure ranges from .54 to 
.92 (Hunter & O’Dea, 2001). The symptom portion of the MRQ was scored by summing 
the scores for all of the items (0, 1 or 2). The remaining items are scored on a five-point 
scale ranging from strongly agree (5) to strongly disagree (1) and summed to provide a 
total score. In order to score across separate subscales, the total score from each subscale 
is divided by the number of items per subscale.
Symptom Severity. In order to measure the menopausal symptom severity during 
the menopausal transition, the Women’s Health Questionnaire (WHQ; Hunter, 1992) was 
used. As discussed above, the WHQ taps many menopausal symptom domains and has 
very good reliability. The WHQ is a 37-item self-report measure that taps 9 domains: 
depressed mood, somatic symptoms, vasomotor, anxiety/fears, sexual behaviour, sleep 
problems, menstrual symptoms, memory/concentration, and attractiveness. For this 
project, the original WHQ items were reworded to the past tense, because we were asking 
participants about their past experiences during the menopausal transition. The reworded 
questionnaire can be found in Appendix D. This scale has good test-retest reliability with 
correlations ranging from .78 to .96 (Hunter, 2003). The depression scale on the WHQ 
demonstrates excellent concurrent validity with the General Health Questionnaire 
(Goldberg, 1972) (r = .86). The WHQ was scored by adding all items, and then 
reflecting the total score. In the original scoring method for the WHQ, lower scores 
indicate more significant distress. We reflected these scores so that higher scores 
represented menopausal distress.
Neuroticism. The neuroticism subscale from the NEO Five Factor Inventory 
(NEO-FFI; Costa & McCrae, 1992) was included in our measures as a general measure 
of maladjustment and emotional distress. We included this measure to explore the
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relationship between reporting menopausal complaints and neuroticism. This scale 
includes 12 items and can be found in Appendix E. The internal consistency of the 
Neuroticism domain of the NEO-FFI is .92 and demonstrates excellent convergent and 
divergent validity (Costa & McCrae, 1992).
Infrequency. Eight items were included from the infrequency scale of the 
Personality Research Form (PRF; Jackson, 1984). In the PRF, a high number of positive 
responses to the infrequency items indicate poor comprehension, carelessness, confusion 
or passive non-compliance (Jackson, 1984). This measure was included as a response 
style measure to detect non-purposeful responding.
Procedure
Ethical clearance for this study was obtained from Lakehead University’s Senate 
Research Ethics Board, and recruitment materials were given clearance through the 
Department of Communications. All women who were interested in participating in the 
study received a package of questionnaires pertaining to their experiences during their 
menopausal transition. They were told that they would be participating in a study to 
determine how physical and emotional symptoms experienced during the menopause may 
affect one’s attitudes toward the menopausal transition. The participants had the option 
of filling out the questionnaires in “paper and pencil” form or they could answer the 
questions on a secure website.
Before filling out the questionnaires, participants were required to read and fill 
out the consent form found in Appendix F. It was outlined that participation in the study 
was voluntary, that subjects could withdraw from the study at any time without penalty, 
and that all data would remain anonymous and confidential. After signing the consent 
form, participants filled out the General Information Questionnaire, MAS, MRQ, WHQ
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and NEO-FFI. After the participants completed the questionnaires, they were asked to 
read the debriefing form found in Appendix G.
Data Analyses
Descriptive statistics were calculated and examined for statistical outliers, as 
recommended by Tabachnick and Fidell (2007). Outliers were defined as scores greater 
than three standard deviations above or below the mean. Preliminary analyses were 
conducted to determine the internal consistency and reliability of the measures.
In our original design, we had planned to analyze statistics on three types of 
treatment: HRT, anti-depressant medication, and psychotherapy. However, we did not 
use treatment through psychotherapy in our main analyses because too few participants 
sought this method of treatment during their menopausal transition (n = 5).
In order to use a single symptom severity scale for our analyses, a composite 
symptom severity score was created. This global symptom severity score was calculated 
by adding the Z scores from the MRQ symptom severity subscale and the WHQ total 
scores and dividing by 2. In addition, only one of our attitudinal measures, the MAS, 
yielded a global score. Therefore, we used the attitudinal subscales of the MRQ for our 
analyses.
As suggested by Tabachnik and Fidell (2007), we used a multiple regression 
procedure for our main analysis to identify whether symptom severity served as a 
significant mediator between menopausal attitudes and the decision to seek HRT, anti­
depressants or psychotherapy. This procedure is suggested when the researcher has only 
two groups and sample sizes are approximately equal (Tabachnik & Fidell, 2007). In this 
case, the dependent variable was coded into no treatment (0) and treatment sought (1). In
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addition, we used discriminant function analyses in order to obtain classification rates to 
supplement our multiple regression equations.
We followed the steps outlined by both Baron and Kenny (1986), and Frazier,
Tix, and Barron (2004) in order to determine if symptom severity served as a significant 
mediator between attitudes and treatment-seeking. First, we regressed treatment seeking 
(the outcome variable) onto the various subscales of attitudes toward menopause (the 
predictor variable) in a number of regression equations to determine which attitudes were 
significantly related to treatment seeking. Next, we regressed symptom severity onto the 
significant attitudinal predictors to determine whether the mediator is related to the 
outcome. Finally, treatment seeking was regressed onto both the symptom severity and 
the significant attitudinal predictors to test whether the mediator is related to the outcome, 
and whether attitudes significantly contribute to treatment-seeking after symptom 
severity has been accounted for in the equation.
Exploratory analyses were conducted on the differences in attitudes, symptom 
severity, and treatment seeking for those who had experienced natural menopause and 
those who had undergone hysterectomies through a number of t-tests. Second, a multiple 
regression analysis was conducted to determine whether various lifetime reproductive 
variables (i.e., significant premenstrual distress, post-partum mood change) significantly 
predicted treatment seeking during the menopausal transition. Third, multiple regression 
analyses were conducted to determine whether demographic and sociological variables 
predict treatment-seeking. Finally, multiple regression analyses were conducted to 
explore whether reproductive and sociological variables predicted a general global rating 
of the menopausal distress (asked in our General Information Questionnaire).
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Results
Data Screening
Prior to data analyses, the raw data for all variables were examined for the 
presence of obvious errors and univariate outliers. Any values exceeding three standard 
deviations above or below the mean were replaced with this (M +/- 3SD) value. In total, 
six values were identified and replaced with a value representing 3 standard deviations 
above or below the mean. Specifically, one score was changed from the MRQ symptoms 
subscale, one score was changed from the MRQ negative impact subscale, two scores 
were changed from the MRQ relief subscale, one score was changed from the MRQ 
control/cure subscale, and one score was changed from the WHQ depressed subscale.
In addition, we examined the infrequency scores to determine whether any 
participants had endorsed over three items, resulting in an invalid questionnaire.
However, no questionnaires were invalidated as no participants endorsed over 3 
infrequency items.
Internal Consistency and Reliability o f Measures
Cronbach’s alpha coefficients were calculated for all measures and their 
corresponding subscales. The internal consistencies, means and standard deviations of all 
subscales can be found in Table 2. The internal consistencies of all measures were quite 
good, although one subscale in the MRQ (long time; a = .35) and one subscale from the 
WHQ (sex behaviour; a = .39) did not perform well. The internal consistency of the 
MAS was .95, the internal consistency of the MRQ subscales ranged from .35 to .80, the 
internal consistency of the WHQ subscales ranged from .39 to .81. The attractiveness
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Table 2
Scale Means, Standard Deviations and Internal Consistencies (n — 95)
Scale Means Standard Deviations Internal Consistency
Menopause Attitude Scale 81.45 20.61 .95
Menopause Representations 
Questionnaire
Symptoms 23.18 7.71 .80
Negative impact 3.22 0.70 .62
Relief 1.88 0.84 .64
New phase 2.92 0.91 .44
Short time 2.89 1.02 .77
Long time 2.67 0.80 .35
Control/cure 2.34 0.88 .61
Women’s Health 
Questionnaire
Depressed mood 0.25 0.21 .59
Somatic symptoms 0.40 0.26 .62
Memory/concentration 0.53 0.37 .62
Vasomotor symptoms 0.77 0.39 .81
Anxiety/fears 0.33 0.34 .74
Sex behaviour 0.52 0.33 .39
Sleep Problems 0.58 0.35 .54
Menstrual Symptoms 0.42 0.35 .69
Attractive1 0.29 0.45
-
NEO Five Factor Inventory 36.85 10.27 .87
Infrequency Measure
U r __________• 1 • . _____________i • ' i
0.13 0.45 .47
Note: single item scale, internal consistency not calculable
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subscale could not be calculated because one item was accidentally omitted from the 
questionnaire, leaving only one item for that particular subscale. Lastly, the internal 
consistency for the NEO-FFI was .87.
Main Analyses
As mentioned above, three regression analyses were used to determine whether 
symptom severity served as a significant mediator between menopausal attitudes and 
treatment seeking. Following these analyses, the mediator was tested for significance 
using a macro program for SPSS described in Preacher and Hayes (2004).
First, various attitudinal variables were entered into the regression analysis in a 
stepwise method to predict treatment-seeking. Panel 1 of Table 3 displays the 
standardized regression coefficients (P), R, adjusted R , and R change. Two attitudinal 
variables emerged as significant predictors of treatment-seeking: the MRQ Negative 
Impact subscale, adjusted R2 = .11, F  (1, 82) = 11.11,/? < .01, and the Menopause 
Attitude Scale, adjusted R2 = .08, F  (1, 87) = 8.48, p  < .01. Other subscales from the 
MRQ did not emerge as significant predictors of treatment-seeking. The correlations 
between all attitude subscales and treatment-seeking can be found in Table 4. When the 
MRQ Negative Impact Subscale was entered into a discriminant function analysis to 
predict treatment group membership (i.e., sought treatment vs. did not seek treatment), 64 
percent of participants were classified correctly. Moreover, when the total scores from 
the MAS were entered into a discriminant function analysis to predict treatment group 
membership, approximately 65 percent of participants were correctly classified into their 
respective treatment groups.
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Table 3
Summary o f Regression Analyses For Testing The Mediation of Symptom Severity Between 
Attitudes and Treatment-Seeking (n = 95)
Variable R Adjusted R2 R 2 Change P
Panel 1: Stepwise MRQ Negative Impact and Treatment-Seeking
MRQ Negative Impact .35 .11 .12** * 35**
MAS Total .30 .08 09** -.007**
Panel 2a: MRQ Negative Impact and Symptom Severity
MRQ Negative Impact .70 .48 .48** _  7 0 **
Panel 2b: MRQ M AS total and Symptom Severity
MAS Total .29 .07
*00o -.29*
Panel 3a: Full Mediation Analysis for MRQ Negative Impact, Symptom Severity and 
Treatment-Seeking
Step 1








Panel 3b: Full Mediation Analysis for MAS Total, Symptom Severity and Treatment-Seeking
Step 1








* p  <  0.05
** p  < 0.01
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Table 4
Correlations between Attitude Subscales and Treatment-Seeking (n = 95)
Variable Name Treatment-Seeking
MAS Total Attitudes r -.23*
MRQ Negative Impact r - .31**
MRQ New Phase r .24*
MRQ Short Time r .00
MRQ Long Time r -.12
MRQ Control/Cure r .15
MRQ Relief r .08
* p  < .05
** p < .01
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Second, the significant attitudinal predictors were each entered into a regression 
equation to determine if menopausal attitudes predict symptom severity (the proposed 
mediator). Panels 2a and 2b of Table 3 display the standardized regression coefficients 
((3), R, adjusted R 2, and R2 change for each of these regression equations. The first 
attitude variable, the MRQ negative impact subscale, significantly predicted symptom 
severity, adjusted R2= .48, F (l, 65) = 60.98, p  < .01. The second attitude variable, the 
total scores from the MAS, also significantly predicted symptom severity, adjusted R = 
.06, F  (1, 61) = 5.54, p  < 0.05.
Third, sequential regression analyses were performed on each significant 
attitudinal variable to determine whether symptom severity is a significant mediator in
the relationship between menopausal attitudes and treatment seeking. Panels 3a and 3b of
2 2Table 3 display the standardized regression coefficients (P), R, adjusted R , and R 
change for each of these regression equations. For the first regression equation, the 
Global Symptom variable was entered first, followed by the MRQ Negative Impact 
subscale. When entered into the equation, the Global Symptom variable was significant, 
adjusted R2 = .13, F ( l ,  65) = 11.26,p <  .01. When MRQ Negative Impact was entered 
into the equation, it remained significant, adjusted R2 = .16, F (2, 64), p < 0.01, but did 
not significantly improve R2, indicating that the Global Symptom measure mediated the 
relationship between the MRQ Negative Impact subscale and Treatment-Seeking. 
Classification rates were determined using a disciminant function analysis, which 
indicated that approximately 70 percent of participants were correctly classified into their 
respective treatment groups using both the Global Symptom variable and MRQ Negative 
Impact subscale.
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For the second regression equation, the Global Symptom variable was entered 
first, followed by the MAS Total Score variable. When entered into the equation, the 
Global Symptom variable was significant, adjusted R = .14, F  (1, 61) = 10.57, p  < .01. 
When the MAS Total Score variable was entered into the equation, it remained 
significant, adjusted R2 = .13, F (2, 60) = 6.85, p  < .01, but did not significantly improve 
R , indicating that the Global Symptom measure mediated the relationship between the 
MAS Total Score variable and Treatment-Seeking. When the MAS total variable and 
Global Symptom variable were entered into a discriminant function analysis, 
approximately 63 percent of participants were correctly classified into their respective 
treatment groups.
Finally, for both regression equations, we used a formula outlined by Frazier, Tix, 
and Barron (2004) to determine whether the relationship between the significant 
menopausal attitudes and treatment-seeking was significantly reduced after symptom 
severity was entered into the equation. According to Frazier et al. (2004), the mediated 
effect divided by its standard error yields a z score of the mediated effect. If this score is 
greater than 1.96, the effect is significant. For the first regression equation, z = - 3.06, 
indicating that symptom severity served as a full mediator between MRQ negative impact 
and treatment-seeking. For the second regression equation, z = - 1.97, indicating that 
symptom severity served as a full mediator between the MAS variable and treatment- 
seeking.
Supplementary Analyses
Comparison of Symptom Means for Women Seeking Treatment versus No Treatment
A r-test was conducted to compare whether women who had sought treatment 
differed from women who had not sought treatment in terms of their symptom severity
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scores. Women who had sought treatment (M  = 0.24, SD = 0.93) differed significantly 
from women who had not sought treatment (M = -0.28, SD = 0.90), t (81) = -2.56, p <
.05, indicating that women who had sought treatment experienced a greater number of 
symptoms and/or more severe symptoms than women who had not sought treatment. 
Comparison of Means for Treatment Groups
A series of one-way ANOVAs were performed to determine whether the 
treatment groups (i.e., no treatment, HRT treatment, and anti-depressant treatment) 
differed in terms of symptoms experienced or menopausal attitudes. A significant 
difference was found between the groups for the Global Symptom Severity variable, F  (2, 
58) = 6.01, p  < .01, with anti-depressant treatment group experiencing the most 
symptoms (M = 0.86, SD -  0.71), followed by the HRT treatment group (M = 0.22, SD = 
0.86), and the no treatment group (M = -0.26, SD = 0.84). Another significant difference 
was found between the groups for the MRQ Negative Impact variable, F (2, 78) = 7.84, p  
< .01, with the anti-depressant treatment group experiencing the greatest negative impact 
(M  = 2.62, SD = 0.71), followed by the HRT treatment group (M = 3.15, SD = 0.64), and 
the no treatment group (M = 3.46, SD = 0.61).
Reproductive Predictors of Treatment-Seeking
A number of reproductive variables from our General Information Questionnaire 
were entered into a regression equation predicting treatment-seeking in a stepwise 
manner. These included: age when menopause began, how long the menopausal 
transition lasted, number of times pregnant, number of biological children, negative mood 
change experienced during the postpartum period, formal diagnosis of postpartum 
depression, number of different sexual partners, age at menarche, mood change during 
puberty, characteristics of menstruation, use of oral contraceptives, mood change due to
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oral contraceptive use, significant trouble associated with premenstrual distress (PMS), 
and mood change associated with premenstrual symptoms. None of these reproductive 
variables emerged as significant predictors of treatment-seeking.
Social and Demographic Predictors of Treatment-Seeking
A number of social and demographic variables from our General Information 
Questionnaire were entered into a regression equation predicting treatment-seeking in a 
stepwise manner. These included: marital status, ethnicity, level of education, episode(s) 
of depression not associated with childbirth, whether or not participant smokes, 
satisfaction with social life during the menopausal transition, satisfaction with work 
during the menopausal transition, familial support during the menopausal transition, 
whether the participant was physically active during the menopausal transition. One 
sociological variable, satisfaction with one’s social life during the menopausal transition, 
emerged as significant, adjusted R = .06, F  (1, 79) = 6.5, p < .05.
Comparison of Means Between Natural and Surgical Menopause
A series of Mests were conducted to determine whether women who had 
experienced natural menopause differed significantly on the menopausal attitude 
variables, symptom severity, or treatment seeking. For the MAS total variable, there was 
a significant difference between women who had experienced natural menopause (M  = 
81.44, SD = 20.61) and those who had undergone hysterectomies (M  = 92.05, SD = 
24.91), t (107) = - 2.00, p  < 0.05. This indicates that women who had undergone 
hysterectomies had a more positive general attitude towards menopause than women who 
had experienced natural menopause. There was also a significant difference on the MRQ 
Negative Impact Subscale for women who had experienced natural menopause (M  =
3.22, SD = 0.70) and those who had undergone hysterectomies (M = 3.24, SD = 0.74), t
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(99) = 2.00, p < 0.05. This indicates that women who had experienced natural 
menopause felt that menopause had had a greater negative impact on their lives than 
women who had undergone hysterectomies.
General Rating of Menopausal Distress
A number of analyses were conducted on a variable that served as a general rating 
of emotional and physical stress during the menopausal transition. This variable asked 
participants to rate how emotionally and/or physically distressing the menopausal 
transition was on a seven-point Likert scale.
First, a multiple regression analysis was completed to determine whether the 
general menopause distress rating significantly predicted treatment-seeking. The general
■y
rating of distress did significantly predict treatment seeking, adjusted R = .13, F (1, 92) = 
15.36, p  < .01.
Second, we entered 18 reproductive variables into a stepwise regression equation 
to predict general emotional and physical distress during the menopausal transition. One 
reproductive variable, length of menopausal transition, emerged as a significant predictor 
of general physical and emotional distress, adjusted R2 = .14, F  (1, 55) = 10.07, p  < .01.
Third, we entered 10 social and demographic variables into a stepwise regression 
equation to predict general emotional and physical distress during the menopausal 
transition. One social variable, dissatisfaction with one’s social life during the 
menopausal transition, emerged as a significant predictor, adjusted R2 = .09, F  (1, 79) = 
8.71, p < .01.
NEO-FFI Scores. Menopausal Symptoms, and Treatment-Seeking
The total NEO-FFI scores were correlated with all symptom variables to 
determine whether neuroticism is related to symptom reporting. The neuroticism scores
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were only significantly correlated with two symptom variables: WHQ sex behaviour, r 
(91) = .30, p < .01, and WHQ attractiveness r (94) = .22, p < .05. Next, we entered the 
NEO-FFI total scores into a regression equation to see whether neuroticism significantly 
predicted treatment-seeking, but we found that the regression equation was not 
significant.
Discussion
The primary aim of this study was to test symptom severity as a mediator in the 
relationship between menopausal attitudes and treatment-seeking. Many studies to date 
have found a significant relationship between menopausal attitudes and treatment- 
seeking, as well as symptom severity and treatment-seeking, but no such studies have 
investigated the possible mediation effects of symptom severity on the relationship 
between menopausal attitudes and treatment-seeking.
Main Hypothesis
The obtained results partially supported our main hypothesis. In our regression 
equations, we found that two attitudinal variables were significantly related to treatment- 
seeking, and our Global Symptom Severity variable. Moreover, we found that our Global 
Symptom Severity variable significantly predicted treatment-seeking. Finally, we found 
that our Global Symptom Severity variable served as a significant mediator between 
menopausal attitudes and treatment-seeking. Unexpectedly, there was an overall weaker 
relationship between attitudes and treatment-seeking, as only 2 of the 7 attitudes entered 
into the equation emerged as significant.
These results are analogous to Ekstrom and colleagues’ (2003) findings, although 
there were some significant differences between the two studies. Although Ekstrom and 
colleagues did not directly test the possible mediation effect of symptom severity on
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treatment-seeking, they did find that health-related factors explained the most variance 
when exploring the relationship between attitudes toward HRT and HRT use. Our study 
used attitudes toward menopause rather than attitudes toward HRT, and used HRT and 
anti-depressant medication for treatment-seeking rather than HRT alone. Despite these 
differences in measurement, it is clear that symptom severity is very important in 
explaining the relationship between attitudes and treatment-seeking, whether it is solely 
HRT, or a combination of HRT and anti-depressant medication.
Our finding that symptom severity serves as a mediator for treatment-seeking 
contradicts the findings of Breheny and Stephens (2001), who found that attitudes toward 
HRT predicted HRT use over and above health variables, such as physical symptoms 
experienced during the menopausal transition. However, when doing their analyses, these 
researchers used women who had passed or reached menopause. Although Breheny and 
Stephens (2001), found that health variables were less important as predictors than 
attitudes, one could argue that by using women who had not fully completed menopause, 
their results may have been confounded. It is possible that women who have not yet 
completed menopause may experience more severe symptoms in the future, and may 
eventually seek HRT treatment. In fact, Breheny and Stephens (2001) found that older 
women were significantly more likely to be using HRT than the younger women in their 
study. Our study analyzed women who had already passed the menopausal transition, 
and therefore had experienced the worst of their symptoms. Although a retrospective 
study introduces some bias, it ensures that participants’ menopausal symptoms had 
dissipated, and there was no possibility that they would seek HRT in the future.
It is important to note that Breheny and Stephens (2001) measured attitudes 
toward HRT, while we measured attitudes toward the menopausal transition, which may
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partially explain the discrepancy with our findings. Although Breheny and Stephens 
(2001) found that attitudes toward HRT were significant predictors of HRT use, they 
found that attitudes toward menopause were not. This contradicts our findings, which is 
likely explained by their use of a different scale to measure menopausal attitudes. The 
scale they used yielded a total menopausal attitude score, while we used separate 
subscales for different types of menopausal attitudes. Although using a measure with 
many subscales is more cumbersome, we felt that a using such a scale would more 
accurately capture menopausal attitudes than a single polarized scale (i.e., positive vs. 
negative attitude toward the menopausal transition). It is likely that using a more 
comprehensive measure of menopausal attitudes yielded more information, and therefore, 
a stronger relationship with treatment-seeking.
Although we did find that two attitudinal predictors were related to treatment- 
seeking, our results indicate that attitudinal predictors were not as robust as expected.
We entered many attitudinal predictors thought to be associated with treatment seeking 
(i.e., feelings of lack of control over the menopausal transition, feelings that menopause 
would last a long time, etc.) into our regression equation, but only two variables emerged 
as significant: general perceptions of the menopausal transition, and perceptions that 
menopause had a negative impact on one’s life.
One possible explanation for this result is that our sample size was not large 
enough to detect significant attitudinal predictors if they were present. However, none of 
the attitudinal predictors neared a significant level, the closest being p = .10. It is likely 
that none of the other menopausal attitudes would significantly predict treatment-seeking 
with the addition of more participants.
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A second explanation could be that we did not accurately capture menopausal 
attitudes with our MRQ scale, because we omitted one item on the control/cure subscale 
as an oversight. However, this variable did not near significance (p = .19), and it is 
unlikely that the missing item would have brought the control/cure variable to a 
significant level.
Third, it is possible that our study did not fully capture attitudes during the 
menopausal transition because of the retrospective nature of our questionnaire. It is 
possible that women had a different attitude toward menopause while they were going 
through the menopausal transition than they did when they had completed menopause. In 
this case, it is possible that women’s attitudes may have significantly predicted treatment- 
seeking during menopause, but had since evolved, rendering them as non-significant 
predictors of treatment-seeking at the current time. However, we repeatedly reminded 
participants to remember and report menopausal attitudes they had at the time of their 
menopausal transition. Unfortunately, it is impossible to determine whether or not the 
participants followed through with our instructions. In the future, this problem could be 
remedied by conducting our study in a prospective manner, in order to track changes in 
menopausal attitudes as women progress through the menopausal transition.
A fourth explanation for why the attitudinal variables were not strong predictors 
of treatment-seeking might be because there is a difference between the attitudes of 
women who filled out the questionnaire online versus women who filled out the paper- 
and-pencil version of the questionnaire. In order to follow-up on this possibility, we 
conducted a number of one-way ANOVAs to ensure that these two groups of women did 
not differ. The two groups of women did not differ in age, employment, symptoms 
experienced, or any of the MRQ attitude subscales. They did, however, differ on the
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MAS. This indicates that women who filled out the questionnaire online had a more 
negative general attitude toward menopause than women who completed the paper-and 
pencil version of the questionnaire. When looking at attitudes based on their own 
menopausal experiences, these two groups of women did not differ. It is possible that 
women who preferred to complete the questionnaire online are more “computer-savvy” 
and have access to more information than women who completed the questionnaire 
through the paper-and-pencil method. If they do have more access to information, they 
may have a more negative attitude toward menopause because they are exposed to 
increased media coverage regarding menopause, health articles, or other women’s 
accounts of their own menopausal transition. Because the MAS already emerged as a 
significant attitudinal predictor, we are not concerned that the difference between the two 
groups of women confounded our attitudinal predictors and made them less significant. 
Comparison of Symptom Means for Women Seeking Treatment vs. No Treatment
Our results indicated that women who had sought treatment experienced a greater 
number of symptoms than women who had not sought treatment. This is consistent with 
previous findings that women who start HRT tend to report more frequent hot flashes, 
night sweats, mood swings, irritability, and sleep problems prior to their HRT initiation 
(Bosworth et al., 2005).
Comparison of Means for Treatment Groups
When we compared differences in means for women who had not sought 
treatment, women who had sought HRT, and women who had sought anti-depressant 
medication, we found that these women only differed in terms of symptom severity, and 
one attitudinal variable: negative impact of menopause. This is consistent with most of 
our other findings, although the differences in means for the MAS variable was non­
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significant. This is likely because the MAS variable was not as strong of a predictor of 
treatment-seeking when compared to the MRQ negative impact variable.
Reproductive Predictors of Treatment-Seeking
Our results indicate that past reproductive events did not predict treatment- 
seeking. This finding was unexpected because many previous studies have found a link 
between past reproductive events and depression during the menopausal transition 
(Dennerstein, Lehert, Burger, & Dudley, 2005; Harlow, Cohen, Otto, Spiegelman, & 
Cramer, 1999). It is likely that the discrepancy between our research and past literature 
stems from the fact that we did not measure depressive symptoms directly, but the 
decision to seek treatment for such symptoms if they exist. It is possible that many of the 
women in our sample suffered from depressive symptoms during the menopausal 
transition, but decided not to alleviate these symptoms by seeking HRT or anti-depressant 
medication. To ensure that this was not the case, we conducted a follow-up analysis to 
determine whether the reproductive variables predicted depressive symptoms during the 
menopause (measured by the WHQ depressed mood subscale). However, none of our 
reproductive variables emerged as significant predictors of depressed mood during the 
menopausal transition.
Another possible reason why we failed to find an association between past 
reproductive events and treatment-seeking is because this relationship was not our main 
focus. When we were developing our General Information Questionnaire, we were 
concentrating on obtaining broad background information. We included questions on 
past reproductive events, because we thought that analyses on these variables would be 
interesting and informative. However, many of these reproductive variables were 
composed of one item, and no definitive conclusions can be drawn without using a more
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reliable measure. In the future, it would be beneficial to create and use a 
psychometrically-sound measure of past reproductive events when doing such an 
analysis, in order to ensure the reliability of the information gathered.
Social and Demographic Predictors of Treatment-Seeking
One social variable, dissatisfaction with one’s social life during menopause, 
significantly predicted treatment-seeking during the menopausal transition. There are 
two possible explanations for this finding. Women who do not have an active social life 
might not have alternative resources (i.e., support from friends and family) for coping 
with the menopausal transition, so they may seek out treatment more readily. 
Alternatively, it is likely that women who experience less severe symptoms (and 
therefore do not seek treatment) may have a more active social life because they are less 
preoccupied with their menopausal transition, and more willing to participate in social 
activities. A prospective design might be helpful in disentangling these two explanations. 
Comparison of Means Between Natural and Surgical Menopause
Our results showed that women who had experienced surgical menopause had a 
more positive general attitude toward menopause than women who had experienced 
natural menopause. Further, our results indicated that women who had experienced 
surgical menopause felt that menopause had less of a negative impact on their lives than 
women who had experienced natural menopause. This is perhaps because women who 
had undergone hysterectomies could attribute their menopausal symptoms directly to the 
surgical procedure, while women who had experienced natural menopause may 
negatively attribute their menopausal changes to aging, loss of youth, or other events in 
their life (i.e., diet, exercise, etc.). However, other studies examining the difference 
between women who had undergone hysterectomies and women who had experienced
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natural menopause have reported that women who experience surgical menopause often 
have a more negative view of the menopausal transition (see Dennerstein, 1996; Papini, 
Intrieri, & Goodwin, 2002; Sievert & Espinosa-Hemandez, 2003).
General Rating of Menopausal Distress
As expected, the obtained results indicated that our general rating of physical and 
emotional distress significantly predicted treatment-seeking. This result is consistent 
with our finding that women who sought treatment experienced more menopausal 
symptoms than those who did not, and consistent with previous research that has reported 
that more severe symptoms predict HRT use (Bosworth et al., 2005).
Next, our results indicated that one reproductive variable, length of one’s 
menopausal transition, emerged as a significant predictor of general physical and 
emotional distress. This finding is not surprising, as women who experience troublesome 
menopausal symptoms for a longer period of time are likely to experience increased 
physical and emotional distress.
Finally, one social and demographic variable, dissatisfaction with one’s social life 
during the menopausal transition, emerged as a significant predictor of general physical 
and emotional distress. This is consistent with our findings that dissatisfaction with one’s 
social life predicts treatment-seeking. As mentioned above, it is difficult to determine the 
direction of this association, and a prospective study would help clear up this 
relationship.
NEO-FFI Scores, Menopausal Symptoms, and Treatment-Seeking
We found that neuroticism was significantly correlated with only two symptom 
variables: WHQ sex behaviour and WHQ attractive. This indicates that women who tend 
to be more neurotic also experience more sexual symptoms during the menopausal
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transition, and tend to feel less attractive than women who are less neurotic. It could be 
argued that attractiveness and sexuality are more closely related to each other than the 
other symptom variables. It is likely that more neurotic women tend to worry about their 
appearance to others, which would influence how attractive they feel, either physically or 
sexually. However, this is a correlational analysis, so no firm conclusions can be drawn. 
Strengths and Limitations of the Study
It is important to note the limitations of this study, the first being the limited 
number of participants in the study. A larger sample would have increased the statistical 
power of the study. Another limitation is the retrospective nature of our research design. 
As in any retrospective study, our results were likely affected by retrospective bias. 
Although a prospective design would be ideal, time parameters did not allow for this. 
Instead, we tried to eliminate bias by continually reminding the participant of the time 
period to which the scales were referring. Finally, the majority of our participants were 
Caucasian, which may have influenced the results of this study. Although our recruiting 
materials were targeted to be inclusive and appealing to all ethnicities, few participants 
from other ethnicities volunteered for this study.
Despite the limitations of this study, there were a number of strengths. First, we 
used more than one measure for both attitudes and menopausal symptoms in order to 
gather a broad spectrum of both variables. Secondly, the measures we used were quite 
comprehensive, with many subscales, which provided us with more information to utilize 
in our analyses. Third, we gathered information from women who had undergone 
hysterectomies, which provided us with valuable and interesting information to carry out 
some supplementary analyses. Finally, we included psychotherapy as part of our 
treatment-seeking variable. Although we did not use this information in our analyses, we
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did gain valuable information in that psychotherapy is not a common treatment for 
women suffering from distressing menopausal symptoms.
Directions for Future Research
In the future, it would be ideal to track participants’ symptoms and attitudes in a 
prospective manner. This would clear up questions regarding some of the relationships 
that we found with this study, and provide interesting information as to whether one’s 
attitudes shift over the menopausal transition. As mentioned above, it would be 
beneficial to have a psychometrically-sound measure of past reproductive events in order 
to further investigate the relationship between reproductive variables and treatment- 
seeking. Additionally, it would be valuable to have a more ethnically-representative 
sample of the population in future studies, in order to determine whether the relationships 
found in this study hold true for people with differing ethnicities.
Future studies in this field should concentrate on sources of menopausal 
information and other ways in which menopausal attitudes can be formed (other than via 
their physical symptoms). For example, it was interesting to find a significant difference 
in general menopausal attitude for women who completed our survey online versus those 
who did not. Future studies could explore this relationship further by investigating how 
influential the media and internet might be in the formation of attitudes versus the 
testimonies of friends and family.
In summary, the menopausal transition is a significant reproductive event for 
women ranging in age from 40 to 60. Moreover, it often causes a great deal of physical 
and emotional distress. Although previous research has focused on the importance of 
attitudes in women’s decisions to seek HRT, our results indicated that symptom severity 
served as a significant mediator between menopausal attitudes and the decision to seek
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HRT or anti-depressant medication. It will be important in the future for studies to use a 
prospective design in order to further explore the relationship between attitudes, symptom 
severity and treatment-seeking.
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Appendix A: General Information Questionnaire




□  Single □  Dating D
□  Widowed □











No □  Retired □
6) If you are employed, do you work: Full Time □ Part Time □
7) Do you perform any type of regular childcare? Yes D No D
8) If yes, how often?
9) What is the highest level of education that you have achieved?
Some high school D




Undergraduate degree D 
Master’s Degree D
Ph.D. Degree D
10) How old were you when you started menopause?
11) Approximately how long did your menopause last?
12) Was your menopause surgically induced?
years months
Yes □  No □
13) How many times have you been pregnant?
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14) How many biological children do you have? _____________
15) If you have ever given birth, did you experience any type of negative mood 
change during the postpartum period?
Yes D No D Unsure D
16) If yes, were you formally diagnosed with postpartum depression?
Yes □  No □
17) If yes, did you receive any treatment for your negative mood change?
Yes D No 0
18) How many different sexual partners have you had in your entire lifetime?______
19) Have you had a past episode of depression not associated with childbirth (prior 
to menopause)?
Yes □  No □
20) If YES, how many depressive episodes? _________________
21) If YES, at what age did the depressive episode(s) occur? _________________
22) If YES, what kind of treatment did you receive? _________________
23) Did you use anti-depressant medication prior to menopause?
Yes □  No □
24) Did you ever take Hormone Replacement Medication prior to menopause?
Yes □  No □
25) Prior to your menopausal symptoms, did you have a tubal ligation (i.e. have 
your “tubes tied”?
Yes □  No □
26) Prior to your menopausal transition, did you have any reproductive surgery? 
(i.e. your ovaries removed, cyst removal from your ovaries, etc.)
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Appraisals in Menopause 58
Yes D  No D
27) Prior to your menopause, did you have any surgery that would affect the 
endocrine system? (i.e., adrenal glands, pituitary gland, thyroid gland?)
Yes D  No D
28) How old were you when you first started menstruating? _________________
29) I believe that going through puberty affected my mood: (Circle the best answer)
Very Slightly In no way at all Slightly Very
Negatively Negatively Positively Positively
0 1 2  3 4






Distressing and discomforting D
31) Have you used oral contraceptives in the past? Yes □  No □
32) IF YES, how long did you continue to use oral contraceptives?
33) IF YES, I believe that using oral contraceptives affected my mood: (Circle the 
best answer)
Very Slightly In no way at all Slightly Very
Negatively Negatively Positively Positively
0 1 2  3 4
34) Prior to menopause, did you have any significant trouble with premenstrual 
distress (PMS)?
Yes □  No □
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35) If YES, please elaborate on your trouble with premenstrual distress (PMS):
36) I believe that my premenstrual distress (PMS) affected my mood: (Circle the 
best answer)
Very Slightly In no way at all
Negatively Negatively
0 1 2
37) Do you Smoke? Yes D No D
38) Did you seek any of the following treatments during your menopausal transition 
(check all that apply):
Hormone Replacement Therapy (e.g., estrogen, progesterone, estradiol) D
(common names include: Premarin, Cenestin, Estrace, Provera, Prempro, Activella)
If yes, please specify: _______________________________________
Anti-depressant medication D
(examples include: Paxil, Effexor, Prozac, Celexa, Welbutrin, Trazodone, etc.)
If yes, please specify:_______________________________
Psychotherapy or Counselling (specifically for menopausal complaints) D
(examples include: Cognitive-Behavioural Therapy, marital therapy, supportive 
counselling, etc.). Please do not include therapy for other issues occurring at that 
time (i.e., therapy specifically for divorce, anxiety, etc.)
Slightly Very
Positively Positively
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Please circle on a scale of 1-7 the extent to which you agree with the following 
statements:
39) My menopausal transition caused me a significant amount of emotional and 
physical stress:
1 2 3 4 5 6 7
Strongly Neutral Strongly
Disagree Agree
40) I was satisfied with my social life during my menopausal transition:
1 2 3 4 5 6 7
Strongly Neutral Strongly
Disagree Agree
41) I was satisfied with my line of work during my menopausal transition:
1 2 3 4 5 6 7
Strongly Neutral Strongly
Disagree Agree
42) I felt like I had a lot of familial support during my menopausal transition:
1 2 3 4 5 6 7
Strongly Neutral Strongly
Disagree Agree
43) I was physically active during my menopausal transition:
1 2 3 4 5 6 7
Strongly Neutral Strongly
Disagree Agree
For the following questions, please circle TRUE if the statement describes you AT THE 
PRESENT TIME and FALSE if it does not describe you AT THE PRESENT TIME.
44) I could easily count from one to twenty-five.
45) I have never talked to anyone by telephone.
46) I make all my own clothes and shoes.
47) Things with sugar usually taste sweet to me.
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Appendix B: Menopause Attitude Scale
INSTRUCTIONS: The following sets of adjectives describe feelings some women may 
experience during menopause. There are no right or wrong answers, only your own 
opinion. You are asked to indicate the degree to which you think the sets of adjectives 
are related to feelings a woman may experience during menopause.
FOR EXAMPLE
If you think that feelings a woman has during menopause are extremely related to one 
end of the scale, you might place your check mark as follows:
DURING MENOPAUSE A WOMAN FEELS
Good X :____ :____ :____ :____ :____ :_____ Bad
If you think that feelings a woman has during menopause are quite related to one end of 
the scale, you might place your check mark as follows:
DURING MENOPAUSE A WOMAN FEELS
Good  :____ :____ :____ :____ : X :_____ Bad
If you think that feelings a woman has during menopause are slightly related to one end 
of the scale, you might place your check mark as follows:
DURING MENOPAUSE A WOMAN FEELS
Good  :____ : X : :____ :____ :_____ Bad
If you think feelings a woman has during menopause are related to both ends equally, 
place your check mark in the middle space.
DURING MENOPAUSE A WOMAN FEELS
Good  :____ : : X :____ :____ :_____ Bad
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DURING MENOPAUSE A WOMAN FEELS:
Important ______ :_____ :_______ :______ :______ :_____ :______  Unimportant
Passive ______ :______ :______ :______ :______ :______ :______  Active
Clean  :______:_______:______ :______ :_____ :______  Dirty
Fresh  :______ :_______:______ :______ :_____ :______  Stale
Dumb  :______ :_______:______ :______ :_____ :______  Intelligent
Sharp  :______:_______:______ :______ :_____ :______  Dull
Unsure  :______:_______ :______ :______ :_____ :______  Confident
Worthless ______ :______:_______:______ :______ :_____ :______  Valuable
High  :______ :_______:______ :______ :_____ :______  Low
Strong ______:_____ :_______ :______ :______ :_____ :______  Weak
Unattractive ______ :_____ :_______ :______ :______ :_____ :______  Attractive
Pessimistic ______ :______:_______:______ :______ :_____ :______  Optimistic
Full________  :______:_______:______ :______ :______:______  Empty
Pleasant ______ :______:_______:______ :______ :______:______  Unpleasant
Ugly_______ :______ :______ :______ :______ :______ :______  Beautiful
Needed ______:______:_______:______ :______ :______:______  Unneeded
Useful ______:______ :______ :______ :______ :______ :______  Useless
Interesting ______ :______:_______:______ :______ :_____ :______  Boring
Unsuccessful_______:_____ :_______:______ :______ :______:______  Successful
Alive______  :______ :_______:______ :______ :_____ :____ Dead
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Appendix C: Menopause Experiences Questionnaire
Please rate to what extent the following experiences were part of your menopause by ticking: 
Yes (part of my menopause),
Uncertain (whether part of my menopause)
No (not part of my menopause).
Please remember that you are ticking the symptoms experienced during menopause, not at 
the current time.
YES UNCERTAIN NO
Tiredness r i [ ]
Hot flashes [ ] [ ] [ ]
Aches and pains [ 1 [ ]
Headaches [ 1 [ ] [ I
Sleep difficulties I J [ ] [ 1
Dizziness [ 1 [ ] [ I
Irregular periods [  ] [ I
Depression [ ] [ ] [ I
Feeling bloated A .  [  1 I 1
Skin problems [  ] [ 1 [  I
Mood swings [ I
Night sweats [  1 [ i [ I
Memory loss [ ] [  I
Heavy periods [ ] [ ] [ I
Anxiety [ ] [ I
Breathlessness [ ] [ I
Vaginal dryness [ 1 [  I
Decreased sexual interest [ ] [ ] [ 1
Increased weight r i [ I
Stiff joints [ ] [ i [ ]
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We are interested in your own personal views of how you see your menopause. Please 
indicate how much you agree or disagree with the following statements about your 




Agree Neutral Disagree Strongly
Disagree
1) Going through menopause has had an 
impact on my life.
2 3 4 5
2) It’s a relief to be free from the risk of 
pregnancy.
1 2 3 4 5
3) At the time, I thought my menopause 
would last about a year.
2 3 4 5
4) The menopause has affected the way I 
see myself as a person.
1 2 3 4 5
5) Overall, I feel that I coped reasonably 
well with my menopause.
1 2 3 4 5
6) I feel less confident since the 
menopause.
1 2 3 4 5
7) At the time, I felt my menopause 
would last a long time.
1 2 3 4 5
8) If I had problems during the 
menopause, I knew what I could do to 
help myself.
1 2 3 4 5
9) I felt more content during this phase of 
life.
2 A;; 3V :.v ' ; 5 ,
10) The menopause has affected the way 
others see me.
l 2 3 4 5
11) I was pleased that periods came to an 
end.
y: 2 r  : 3 ;̂V.'V4 5
12) At the time, I felt more emotional 
than I did before menopause.
1 2 3 4 5
13) At the time, I felt it was good to be 
moving into a new phase of life.
2 3 4 V ; 5
14) At the time, I was confident that I 
could deal with any changes that my 
menopause might have brought.
1 2 3 4 5
15) At the time, I believed my menopause 
would last a short time.
: i 2 3 4 5
16) At the time, I believed that my 
menopause symptoms would improve in 
time.
i 2 3 4 5
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Appendix D: Women’s Health Questionnaire
Please indicate how you felt duringyour menopausal transition, by putting a circle around the 
number that best describes your experience for each of the following items:










1)1 woke up early and then slept badly 
for the rest of the night. 1 2 3 4
2) I had very frightened or panic feelings 
for apparently no reason at all. 1 2 3 4
3) I felt miserable and sad.
2 3 4
4) I felt anxious when I went out of the 
house on my own. 1 2 3 4
5) I lost interest in things.
i 2 -,.',■■'3,.. 4
6) I got palpitations or a sensation of 
“butterflies” in my stomach or chest. i 2 3 4
7) I still enjoyed the things I used to. 4
8) I felt that life was not worth living. 1 2 3 4
9) I felt tense or “wound up”. 4
10) I had a good appetite. 1 2 3 4
11)1 was restless and couldn’t keep still.
1 ' ISA 4
12) I was more irritable than usual. 1 2 3 4
13) I worried about growing old. A: I :.;A: 4;- ;
14) I had headaches. 1 2 3 4
15) I felt more tired than usual.
4;:; v  ̂ 2 0 $ : 3 AA; A '
16) I had dizzy spells. 1 2 3 4
17) My breasts felt tender or 
uncomfortable. 3
18) I suffered from backache or pain in 
my limbs. 1 2 3 4
19) I had hot flashes. 2 3 4
20) I was more clumsy than usual. l 2 3 4
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22) I had abdominal cramps or 
discomfort. 2 3 4
23) I felt sick or nauseous. 1 2 3 4
24) I lost interest in sexual activity. 1 2 3 4
25) I had feelings of well-being. 1 2 3 4
26) I had heavy periods. 2 3 4
27) I suffered from night sweats. 1 2 3 4
28) My stomach felt bloated. 1 2 3 4
29) I had difficulty getting to sleep. 1 2 3 4
30) I often noticed pins and needles in 
my hands and feet. 2 ■ V 3 4
31)1 was satisfied with my sexual 
relationship. 1 2 3 4
32) I felt physically attractive.
2 3 - - V .
33) I had difficulty concentrating. 1 2 3 4
34) As a result of vaginal dryness, sexual 
intercourse became uncomfortable. 1 2 3 4
35) I needed to pass urine/water more 
frequently than usual. 1 2 3 4
36) My memory was poor. 1 2 3 4
37) I felt lively and excitable. 1 2 3 4
Was it very difficult for you to cope with any of the above symptoms? [ ] YES
[] NO
If so, which ones:
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Appendix E: NEO Five Factor Inventory




Disagree Neutral Agree Strongly
Agree
1) I am not a worrier. 2 3 4 5
2) I often feel inferior to 
others.
1 2 3 4 5
3) When I’m under a great 
deal of stress, sometimes I 
feel like I’m going to pieces.
1 2 3 4 5
4) I rarely feel lonely or 
blue.
1 2 3 4 5
5) I often feel tense and 
jittery.
\A'1;'7 A 2 3 A. - “v. . . ; . 5 ,V..; ....
6) Sometimes I feel 
completely worthless.
1 2 3 4 5
7) I rarely feel anxious or 
nervous.
; '3 5
8) I often get angry at the 
way people treat me.
l 2 3 4 5
9) Too often, when things 
go wrong, I get discouraged 
and feel like giving up.
1 ;§A ;2  ' 3 4 5
10) I am seldom sad or 
depressed.
1 2 3 4 5
11) I often feel helpless and 
want someone else to solve 
my problems.
2 ; Ov ■ 3 4 5
12) At times I have been so 
ashamed I just wanted to 
hide.
1 2 3 4 5
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For the following questions, please circle TRUE if the statement describes you AT THE 
PRESENT TIME and FALSE if it does not describe you AT THE PRESENT TIME.
49) I have never ridden in an automobile. TRUE FALSE
50) I try to get at least some sleep every night. TRUE FALSE
51) I have attended school at some time during my life. TRUE FALSE
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Appendix F: Menopause Study Consent Form
This study is being conducted by Suzanne Stone, a Master’s candidate in clinical psychology, 
under the supervision of Dr. D. Mazmanian of the Department of Psychology at Lakehead 
University. The purpose of this study is to identify how physical and emotional symptoms 
experienced during the menopause may affect one’s attitudes towards the menopausal transition.
• Your participation in this study will involve the completion of several questionnaires that 
will take approximately 30 to 45 minutes.
• The questionnaires include personal questions about: the symptoms you experienced 
during menopause, your attitudes towards the menopausal transition, and questions about 
your sexual and reproductive history.
• Participation in this study is voluntary and you may withdraw at any time without 
explanation and without penalty.
• All records of your participation will be kept in strict confidence and any reports of the
study will not identify you or anyone as a participant.
• As per university requirements, all data will be stored for seven years by Dr. D. 
Mazmanian at Lakehead University and will remain anonymous and confidential.
• There will be no way that your name can be connected to your responses
• There are no known physical or psychological risks associated with participating in this 
study.
• There will be several items in the questionnaire that appear odd or unrelated. These items 
are included for methodological reasons to ensure the accuracy of the data.
I have read and understood the consent form, and I agree to participate in this study under these 
conditions. By agreeing to participate in this study, I am affirming that I am a woman who has 
completed my menopausal transition.
Name (please print): 
Signature:
Date:
If you have any questions or concerns regarding this study please contact Suzanne Stone 
(sstone@lakeheadu.ca) or the supervisor o f  this study, Dr. Mazmanian ( phone:343-8257, email: 
dwight.mazmanian@lakeheadu.ca).
Other collaborators in the Menopause Research Group include Dr. Kirsten Oinonen (Assistant 
Professor o f Psychology at Lakehead University) and Dr. Verinder Sharma (Professor o f  
Psychiatry and Professor o f Obstetrics & Gynecology at the University o f Western Ontario)
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Appendix G: Debriefing Form
The purpose of this study is to determine how the physical and emotional 
symptoms that a woman experiences during menopause affects both her attitudes toward 
the menopausal transition and her decision to seek help for her menopausal symptoms 
(for example: hormone replacement therapy, anti-depressants or
psychotherapy/counseling). Past research suggests that women with a greater number of 
distressing menopausal symptoms and a more negative attitude toward menopause tend 
to seek hormone replacement therapy (Breheny & Stephens, 2001).
Please be assured that all of your responses are coded to conceal your identity and 
that all data will remain anonymous.
Listed below are some related references which might be of interest to those who 
would like further information on the effect of physical and emotional symptoms of the 
menopause on menopausal attitudes and the decision to seek help during the menopausal 
transition.
If you would like more information on the results of this study, please fill in your 
mailing address or email address on the attached mailing label and a summary will be 
sent to you at the end of this study.
Thank you sincerely for taking the time to participate in this research.
Recommended Readings:
Breheny, M., & Stephens, C. (2001). The importance of attitudes in predicting hormone 
replacement therapy use in mid-aged women in a New Zealand community 
sample. Women & Health, 34 (1), 29-43.
Ekstrom, H., Esseveld, J., & Hovelius, B. (2003). Associations between attitudes toward 
hormone therapy and current use of it in middle-aged women. Maturitas, 46, 
45-47.
Woods, N.F, Saver, B., & Taylor, T. (1998). Attitudes toward menopause and hormone 
therapy among women with access to health care. Menopause: Journal o f the 
North American Menopause Society, 5(3), 178-188.
If you have any questions or concerns regarding this study please contact Suzanne Stone 
(sstone@lakeheadu.ca) or the supervisor of this study, Dr. Mazmanian (phone: 343-8257, email: 
dwight.mazmanian@lakeheadu.ca).
Other collaborators in the Menopause Research Group include Dr. Kirsten Oinonen (Assistant 
Professor of Psychology at Lakehead University) and Dr. Verinder Sharma (Professor of 
Psychiatry and Professor of Obstetrics & Gynecology at the University of Western Ontario)
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
